111 related articles for article (PubMed ID: 12494768)
1. Modulation of alternative splicing by antisense oligonucleotides.
Sazani P; Kole R
Prog Mol Subcell Biol; 2003; 31():217-39. PubMed ID: 12494768
[No Abstract] [Full Text] [Related]
2. Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.
Sazani P; Kole R
J Clin Invest; 2003 Aug; 112(4):481-6. PubMed ID: 12925686
[TBL] [Abstract][Full Text] [Related]
3. RNA modulation, repair and remodeling by splice switching oligonucleotides.
Kole R; Williams T; Cohen L
Acta Biochim Pol; 2004; 51(2):373-8. PubMed ID: 15218534
[TBL] [Abstract][Full Text] [Related]
4. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides.
Taylor JK; Zhang QQ; Wyatt JR; Dean NM
Nat Biotechnol; 1999 Nov; 17(11):1097-100. PubMed ID: 10545916
[TBL] [Abstract][Full Text] [Related]
5. Splicing and dicing apoptosis genes.
Reed JC
Nat Biotechnol; 1999 Nov; 17(11):1064-5. PubMed ID: 10545908
[No Abstract] [Full Text] [Related]
6. Reduction of c-myc expression by an antisense approach under Cre/loxP switching induces apoptosis in human liver cancer cells.
Ebinuma H; Saito H; Kosuga M; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Okuyama T; Ishii H
J Cell Physiol; 2001 Jul; 188(1):56-66. PubMed ID: 11382922
[TBL] [Abstract][Full Text] [Related]
7. Antisense effects in the cell nucleus: modification of splicing.
Kole R; Sazani P
Curr Opin Mol Ther; 2001 Jun; 3(3):229-34. PubMed ID: 11497345
[TBL] [Abstract][Full Text] [Related]
8. Antisense-mediated redirection of mRNA splicing.
Vacek M; Sazani P; Kole R
Cell Mol Life Sci; 2003 May; 60(5):825-33. PubMed ID: 12827272
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of AP-1 transcription activator induces myc-dependent apoptosis in HL60 cells.
Park S; Hahm ER; Lee DK; Yang CH
J Cell Biochem; 2004 Apr; 91(5):973-86. PubMed ID: 15034932
[TBL] [Abstract][Full Text] [Related]
10. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD
Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470
[TBL] [Abstract][Full Text] [Related]
11. Psoralen-modified clamp-forming antisense oligonucleotides reduce cellular c-Myc protein expression and B16-F0 proliferation.
Stewart DA; Thomas SD; Mayfield CA; Miller DM
Nucleic Acids Res; 2001 Oct; 29(19):4052-61. PubMed ID: 11574688
[TBL] [Abstract][Full Text] [Related]
12. [Suppression of expression of bcl-2 and bcl-xL genes using antisense oligonucleotides: a new approach to cancer therapy].
Lebedeva IV; Staĭn SA
Mol Biol (Mosk); 2000; 34(6):1025-38. PubMed ID: 11186002
[No Abstract] [Full Text] [Related]
13. Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-alpha chain.
Karras JG; Maier MA; Lu T; Watt A; Manoharan M
Biochemistry; 2001 Jul; 40(26):7853-9. PubMed ID: 11425312
[TBL] [Abstract][Full Text] [Related]
14. Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing.
Karras JG; McKay RA; Dean NM; Monia BP
Mol Pharmacol; 2000 Aug; 58(2):380-7. PubMed ID: 10908306
[TBL] [Abstract][Full Text] [Related]
15. Modification of alternative splicing of Mcl-1 pre-mRNA using antisense morpholino oligonucleotides induces apoptosis in basal cell carcinoma cells.
Shieh JJ; Liu KT; Huang SW; Chen YJ; Hsieh TY
J Invest Dermatol; 2009 Oct; 129(10):2497-506. PubMed ID: 19369967
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS
Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
[TBL] [Abstract][Full Text] [Related]
17. C-Myc and Bcl-2 protein expression during the induction of apoptosis and differentiation in TNF alpha-treated HL-60 cells.
Kumakura S; Ishikura H; Tsumura H; Iwata Y; Endo J; Kobayashi S
Leuk Lymphoma; 1996 Oct; 23(3-4):383-94. PubMed ID: 9031121
[TBL] [Abstract][Full Text] [Related]
18. Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides.
Dias N; Stein CA
Eur J Pharm Biopharm; 2002 Nov; 54(3):263-9. PubMed ID: 12445555
[TBL] [Abstract][Full Text] [Related]
19. Modulation of biological processes in the nucleus by delivery of DNA oligonucleotides conjugated with gold nanoparticles.
Kim DW; Kim JH; Park M; Yeom JH; Go H; Kim S; Han MS; Lee K; Bae J
Biomaterials; 2011 Apr; 32(10):2593-604. PubMed ID: 21251710
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
